Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06180733
Status:
RECRUITING
Last Update Posted:
2023-12-22
First Post:
2023-12-04
Brief Title:
Neo-adjuvant Pembrolizumab as an Alternative Treatment for MMRd Uterine Cancer
Sponsor:
Organization:
University Medical Center Groningen